GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness ...

Kidney Disease,” an editorially independent special report that was produced with financial support from Vertex. M ore than ...

Clinical and payer strategies should treat GLP‑1 therapy as chronic for high-risk patients, addressing tolerability and cost ...

Metformin use in people with diabetes was linked to a significantly lower risk of developing intermediate age-related macular degeneration.

From online forums to the clinic, people have reported that diabetes and weight-loss drugs such as Ozempic and Wegovy can ...

Off-label adjunctive use requires careful dosing, dose adjustments of insulin and other medications, and close monitoring.

A new study suggests heart health gains disappear in half the time it takes to build them up when people stop taking GLP-1 ...

Researchers found that the risk of type 2 diabetes varies among young adults. Those with high fasting glucose who qualified ...

The landscape of diabetes management is undergoing a remarkable transformation. Groundbreaking research has uncovered surprising cardiovascular benefits tied to modern medications, offering new hope ...

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...

In the United States, over 30 million people suffer from diabetes, while nearly 98 million are classified as pre-diabetic. Unfortunately, rather than addressing the fundamental lifestyle factors that ...

Living with diabetes doesn’t have to mean accepting a lifetime of increasing medication doses and constant worry about blood sugar spikes. While traditional medical approaches focus heavily on ...